Orlistat
Showing 1 - 25 of 109
Type 1 Hyperlipoprotenemia Trial (Orlistat, Placebo)
Not yet recruiting
- Type 1 Hyperlipoprotenemia
- Orlistat
- Placebo
- (no location specified)
Apr 14, 2023
Uric Acid Trial in Shanghai (Orlistat, Orlistat )
Not yet recruiting
- Uric Acid
- Orlistat
- Orlistat placebo
-
Shanghai, Shanghai, ChinaShanghai Tenth People's hospital
Aug 8, 2022
PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, T2D Trial in Nantong (control group: lifestyle intervention+ metformin+
Enrolling by invitation
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- T2D
- control group: lifestyle intervention+ metformin+ orlistat (obese patients)+ pioglitazone
- the experimental group: lifestyle intervention+ metformin+ orlistat (obese patients)+ Chiglitazar
-
Nantong, Jiangsu, ChinaGu Yunjuan
Feb 27, 2023
Hyperlipoproteinemia Type I, Hypertriglyceridemia Trial in Dallas (Orlistat)
Active, not recruiting
- Hyperlipoproteinemia Type I
- Hypertriglyceridemia
- Orlistat
-
Dallas, TexasUT Southwestern Medical Center 5323 Harry Hines Blvd
Jan 23, 2022
Bioequivalence Trial in Linyi (Orlistat 60mg Cap)
Completed
- Bioequivalence
- Orlistat 60mg Cap
-
Linyi, Shandong, ChinaShaohong Yin
Sep 30, 2021
Anovulation, Obesity Trial in Sheffield (Orlistat Vs Metformin)
Completed
- Anovulation
- Obesity
- Orlistat Vs Metformin
-
Sheffield, United KingdomSheffield Teaching Hospitals NHS Trust, Jessop Wing
Sep 21, 2021
Polybrominated Biphenyl Poisoning Trial in Atlanta (Orlistat, Placebo capsule)
Completed
- Polybrominated Biphenyl Poisoning
- Orlistat
- Placebo capsule
-
Atlanta, GeorgiaMichele Marcus
Sep 12, 2022
Overweight or Obesity Trial in Linköping, Uppsala (EMP16-02 120 mg orlistat/40 mg acarbose, EMP16-02 150 mg orlistat/50 mg
Completed
- Overweight or Obesity
- EMP16-02 120 mg orlistat/40 mg acarbose
- +2 more
-
Linköping, Sweden
- +1 more
Apr 1, 2022
Type 1 Hyperlipoproteinemia Trial in Dallas (SLx-4090 , Orlistat Placebo, Orlistat)
Terminated
- Type 1 Hyperlipoproteinemia
- SLx-4090 placebo
- +3 more
-
Dallas, Texas
- +1 more
Jul 26, 2021
Obesity Trial in Loma Linda (Semaglutide, Orlistat, Phentermine/Topiramate)
Recruiting
- Obesity
- Semaglutide
- +4 more
-
Loma Linda, CaliforniaNovo Nordisk Investigational Site
Jan 24, 2023
Obesity Trial in Yazd (orlistat)
Completed
- Obesity
- orlistat
-
Yazd, Iran, Islamic Republic ofResearch and Clinical Center for Infertility
Mar 25, 2021
Type II Diabetes in Subjects BMI 27 to 32 Trial in Singapore (Roux-en-Y Gastric Bypass (RYGB), Incretin analogues, Xenical)
Completed
- Type II Diabetes in Subjects BMI 27 to 32
- Roux-en-Y Gastric Bypass (RYGB)
- +4 more
-
Singapore, SingaporeKhoo Teck Puat Hospital
Jun 22, 2022
Type 2 Diabetes, Obesity Trial in Cleveland (Weight Management Program (WMP), Traditional care, Phentermine / Topiramate
Recruiting
- Type 2 Diabetes
- Obesity
- Weight Management Program (WMP)
- +5 more
-
Cleveland, OhioCleveland Clinic
Jan 28, 2022
Infertility, Female Trial in United States (Caloric Restriction, Orlistat, Moderate physical activity)
Completed
- Infertility, Female
- Caloric Restriction
- +2 more
-
San Francisco, California
- +9 more
Feb 1, 2022
Obesity Trial in Brazil (Orlistat 60 mg, Placebo)
Completed
- Obesity
- Orlistat 60 mg
- Placebo
-
Porto Alegre, RS, Brazil
- +4 more
Apr 6, 2020
Overweight or Obesity Trial in Uppsala (Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical®)
Not yet recruiting
- Overweight or Obesity
- Xenical® vs EMP 22
- +2 more
-
Uppsala, SwedenCTC Clinical Trial Consultanta AB
Aug 25, 2023
Obesity, Overweight Trial in Yongin-si (Orlistat 120Mg Cap, Phentermine Pill)
Completed
- Obesity
- Overweight
- Orlistat 120Mg Cap
- Phentermine Pill
-
Yongin-si, Gyeonggi-do, Korea, Republic ofYongin Severance Hospital
Oct 31, 2019
Obesity, Weight Change, Body, Obesity; Endocrine Trial in Istanbul (bariatric surgey)
Recruiting
- Obesity
- +3 more
- bariatric surgey
-
Istanbul, TurkeyMarmara University Medical School Section of Endocrinology and M
Jun 3, 2020
Obesity, Binge Eating Trial in New Haven (Xenical + behavioral intervention, Behavioral intervention + )
Completed
- Obesity
- Binge Eating
- Xenical + behavioral intervention
- Behavioral intervention + placebo
-
New Haven, Connecticut
- +1 more
Mar 31, 2020
Obesity, Binge Eating Trial in New Haven (Behavioral Weight Loss, Behavioral Weight Loss + Guided self-help Cognitive-behavioral
Completed
- Obesity
- Binge Eating
- Behavioral Weight Loss
- +3 more
-
New Haven, ConnecticutYale School of Medicine
Apr 1, 2020
Ezetimibe and Orlistat Affect Intestinal Flora of
Unknown status
- Hyperlipidemia
- Ezetimibe 10mg
- Orlistat 120 MG
- (no location specified)
Mar 19, 2019
Constipation Trial in Dublin (Fat Microcapsules)
Recruiting
- Constipation
- Fat Microcapsules
-
Dublin, IrelandClinical Research Centre
May 25, 2022
Pediatric Obesity Trial in Palo Alto (Topiramate, Phentermine)
Withdrawn
- Pediatric Obesity
-
Palo Alto, CaliforniaStanford University
May 19, 2022
Safety of Exposure to Wegovy During Pregnancy
Not yet recruiting
- Pregnancy
- +2 more
- No Intervention
- (no location specified)
Aug 16, 2022